Small Cell Lung Cancer Treatment

Small cell lung cancer (SCLC) tends to grow quickly and spread early. For these reasons, treatment often begins soon after the diagnosis is confirmed. The treatment plan will be tailored to the patient’s symptoms, goals and overall health, with a focus on safety, effectiveness and quality of life.

SCLC is generally grouped into two main stages, which can help guide treatment decisions:

• Limited-stage SCLC – The tumor is confined to one lung and nearby lymph nodes and can often be treated within a single radiation field.
• Extensive-stage SCLC – The cancer has spread to the other lung, distant lymph nodes or the bones, liver or brain.

After identifying the cancer stage, the healthcare team will develop an appropriate treatment strategy. Common approaches include chemotherapy, often combined with radiation therapy and immunotherapy. In select cases, surgery may be considered for very early-stage SCLC, particularly when the tumor appears confined to the lung with no lymph node involvement. Even when surgery is an option, additional treatment is usually recommended to reduce the risk of recurrence.

Chemotherapy for small cell lung cancer

Chemotherapy is a cornerstone of SCLC treatment, mainly because this aggressive type of lung cancer tends to spread early, even when imaging suggests it may be localized. Because chemotherapy medications travel through the bloodstream, they can treat cancer cells throughout the body. This systemic treatment may be used:

• Along with radiation therapy and/or immunotherapy for limited-stage SCLC
• As the main treatment for extensive-stage SCLC
• After surgery, in rare early-stage cases, to help reduce the likelihood of recurrence
• To relieve symptoms and improve quality of life when a cure is not possible

Chemotherapy for small cell lung cancer is usually given through an intravenous (IV) infusion. The treatment is delivered in cycles, with rest periods scheduled between active therapy sessions. The specific regimen will be tailored to the stage of the cancer and the patient’s overall health, prior treatments and ability to tolerate therapy.

As we find more mutations or other genetic characteristics of the tumor, the future of cancer is going to be that it can either be cured or controlled.

Eric Toloza, MD, PhD

Cardiothoracic Surgeon

Commonly prescribed chemotherapy drugs for SCLC include:

• Cisplatin
• Carboplatin
• Etoposide
• Irinotecan
• Topotecan
• Lurbinectedin

Potential risks and side effects of chemotherapy for small cell lung cancer

Chemotherapy effectively targets rapidly dividing cells, such as cancer cells. However, it can also affect healthy cells that naturally reproduce quickly. For this reason, side effects are common, often involving the blood, digestive tract and hair follicles. The healthcare team can provide supportive therapies to help manage any symptoms, such as:

• Fatigue and weakness
• Nausea or vomiting
• Loss of appetite
• Diarrhea or constipation
• Hair thinning or hair loss
• Low blood cell counts, which can increase the risk of infection or cause anemia
• Mouth sores or changes in the sense of taste
• Numbness or tingling sensations in the hands and feet (neuropathy), which is common with platinum-based drugs
• Changes in hearing or kidney function, sometimes associated with cisplatin
• Increased risk of dehydration and electrolyte imbalances

Preparing for chemotherapy and recovery between cycles

Before starting chemotherapy, the patient will typically undergo blood work and may receive premedications to help prevent nausea and allergic reactions. The healthcare team may also discuss fertility preservation options if appropriate, since some chemotherapy drugs can affect reproductive health.

Between chemotherapy cycles, recovery often focuses on maintaining strength and monitoring side effects. The healthcare team may recommend:

• Nutritional counseling to support appetite and body weight
• Hydration strategies and medications to manage nausea or bowel changes
• Infection prevention steps if blood cell counts are low
• Periodic lab tests and follow-up visits
• Dose adjustments if side effects become significant

Although many patients can continue their daily activities with some slight modifications, rest and pacing are often essential.

Radiation therapy for small cell lung cancer

Radiation therapy is a localized treatment that uses high-energy beams to destroy cancer cells. For SCLC, the most common approach is external beam radiation therapy (EBRT), which is carefully planned to precisely target the cancer while limiting exposure to the surrounding healthy tissues. Often incorporated into a combined treatment plan for enhanced effectiveness, EBRT may be recommended:

• Along with chemotherapy and/or immunotherapy for limited-stage SCLC
• After chemotherapy, in some cases, to help control cancer in the chest
• To relieve symptoms of extensive-stage SCLC, such as pain, bleeding, coughing or breathing difficulties
• As prophylactic cranial irradiation (PCI) to reduce the risk of lung cancer spreading to the brain

Potential risks and side effects of radiation therapy for small cell lung cancer

The side effects of radiation therapy can vary based on the treatment site, total dose and patient’s health. The healthcare team will monitor any symptoms closely and provide strategies to help manage any discomfort. Common side effects include:

• Fatigue and weakness
• Skin irritation in the treated area
• Esophagitis, which may cause soreness or difficulty swallowing
• Coughing, chest discomfort or inflammation in the lung tissue
• Shortness of breath due to radiation pneumonitis, which may occur weeks to months after treatment
• Long-term scarring of lung tissue (rare)

Additionally, if PCI is used, possible side effects include:

• Headaches
• Impaired memory or concentration
• Hair loss on the scalp

The patient should promptly report worsening chest pain, fever, shortness of breath or coughing, which may signal lung inflammation or infection.

Preparing for radiation therapy and what to expect

Before starting radiation therapy, the patient will participate in a planning session to ensure accurate targeting of the cancer. During this detailed “simulation,” the healthcare team will use imaging scans to map the tumor and surrounding structures, determine the beam angles and doses and create custom immobilization devices, which will help the patient remain properly positioned during each treatment.

While receiving radiation therapy, many patients can continue their normal routines, although fatigue often builds over time. To counter the side effects of treatment, the healthcare team may recommend:

• Eating soft foods, if swallowing becomes difficult
• Staying well-hydrated and maintaining good nutrition
• Using prescribed oral rinses or medications to soothe throat irritation
• Resting as needed and keeping physical activities gentle but consistent

Most side effects gradually improve after treatment ends, although some may take longer to resolve than others.

Rated High Performing in Lung Cancer Surgery

Recognized in U.S. News & World Report's Best Hospitals for significantly better performance in lung cancer surgery than the national average.

Schedule an Appointment

Immunotherapy for small cell lung cancer

Immunotherapy is designed to help the body’s immune system recognize and attack cancer cells. For SCLC, immunotherapy is often combined with chemotherapy, particularly for extensive-stage cancer. It may also be used as a maintenance treatment to help slow cancer progression.

Immunotherapy is commonly given through IV infusions at regular intervals, such as every two, three or four weeks, similar to many chemotherapy regimens. The healthcare team will determine whether immunotherapy is appropriate based on the stage of the cancer and the patient’s overall health and prior treatment response.

Commonly used immunotherapy drugs for SCLC include:

• Atezolizumab
• Durvalumab

Potential risks and side effects of immunotherapy for small cell lung cancer

Unlike chemotherapy, immunotherapy can cause the immune system to become overactive and mistakenly attack healthy tissues. Many patients tolerate immunotherapy well, but symptoms can sometimes become serious without prompt treatment.

Possible side effects of immunotherapy include:

• Fatigue, skin rash, itching or joint aches
• Diarrhea or colon inflammation (colitis)
• Thyroid changes that may cause weight gain or loss, mood swings or temperature sensitivity
• Lung inflammation (pneumonitis), which can cause coughing and shortness of breath
• Liver inflammation (hepatitis)
• Heart, kidney or nervous system inflammation (rare)

The patient should seek immediate medical attention for chest pain, severe shortness of breath, high fever, mental confusion, significant diarrhea or sudden weakness.

Preparing for immunotherapy and ongoing monitoring

Before immunotherapy begins, the healthcare team will review the patient’s medical history and may order baseline blood testing. During treatment, the team will closely monitor the patient’s lab values and symptoms to detect and address any immune-related side effects early.

The patient may be advised to:

• Keep a symptom log and report any changes right away
• Have regular lab work and follow-up visits
• Avoid delaying care for diarrhea, coughing or new fatigue that seems unusual
• Discuss any autoimmune conditions, since immunotherapy may worsen them

Some side effects of immunotherapy can be managed with treatment pauses or medications, such as corticosteroids.

Surgery for small cell lung cancer

Surgery is not a common treatment for SCLC, which frequently spreads rapidly. However, it may be an option for select patients when the cancer is found at a very early stage and appears to be confined to the lung, typically with no evidence of lymph node involvement. Even in these situations, surgery is usually combined with chemotherapy and sometimes radiation therapy to address cancer cells that may be too small to detect on imaging scans.

When surgery is recommended, the specific approach can vary depending on the size and location of the tumor and the patient’s lung function and overall health. Common surgical procedures include:

• Wedge resection – Removal of a small, wedge-shaped piece of lung tissue containing the tumor
• Segmentectomy – Removal of one segment of the affected lobe
• Lobectomy – Removal of one lobe of the affected lung
• Pneumonectomy – Removal of the entire lung (rare for SCLC treatment)
• Lymph node sampling or dissection – Removal of nearby lymph nodes to check for cancer spread

Potential risks and side effects of surgery for small cell lung cancer

While every surgical procedure carries certain risks, lung surgery involves special considerations because it can affect breathing and stamina during recovery. The healthcare team will work closely with the patient to continually monitor lung function and help prevent complications.

Possible side effects of SCLC surgery include:

• Pain or soreness at the incision site
• Shortness of breath, fatigue or reduced exercise tolerance during healing
• Infection, bleeding or pneumonia
• Air leakage from the lung, which may require additional time with a chest tube
• Blood clots, including deep vein thrombosis (DVT) or pulmonary embolism
• Heart complications in patients with certain cardiac risk factors

The patient should contact the healthcare team right away if symptoms such as high fever, worsening shortness of breath, chest pain or leg swelling develop after surgery.

Preparing for small cell lung cancer surgery and what recovery may look like

Before surgery, the patient may undergo breathing tests (pulmonary function testing), imaging, lab work and a cardiac evaluation if needed. The healthcare team may also recommend prehabilitation, such as light physical activity, respiratory exercises and nutritional support to enhance recovery.

After surgery, the healing process can vary depending on the procedure performed and the patient’s baseline health. Some patients may go home within several days, while others might need more time in the hospital for close monitoring and rehabilitation. Before discharge, the patient will receive individualized guidance on:

• Pain management and incision care
• Breathing exercises to reduce pneumonia risk
• Activity progression and returning to normal routines
• Follow-up visits and additional treatment planning, such as chemotherapy

Because small cell lung cancer is often treated with a combination of therapies, surgery (if recommended) is typically only one step in a broader treatment plan.

Targeted therapy and other treatment options for small cell lung cancer

Targeted therapy is not commonly used for SCLC, which does not have the same actionable genetic changes as non-small cell lung cancer. However, targeted therapies and other specialized treatments may be available to select patients based on tumor testing, prior treatments and clinical trial eligibility.

Additional options may include:

• Second-line or later-line systemic therapies for recurrent SCLC
• Supportive therapies, such as nutritional planning, pulmonary rehabilitation, smoking cessation programs, pain management and psychosocial support

Because SCLC can change over time, the healthcare team may recommend repeat imaging, reassessment of the treatment response and potential clinical trial evaluation at key points in the care journey.

Clinical trials for small cell lung cancer

Clinical trials provide certain patients with unique opportunities to access promising new therapies that are not yet widely available. These important research studies can be especially beneficial for a patient with SCLC, which can be challenging to treat and may return after standard treatment. If the patient is interested in participating in a clinical trial, the healthcare team can help them understand the eligibility criteria, explain what participation will involve and discuss the potential benefits and risks. In addition to receiving a groundbreaking treatment, a clinical trial participant can also help shape the future of cancer care.

Frequently asked questions (FAQs) about small cell lung cancer treatment

Many patients have similar questions after receiving an SCLC diagnosis, especially when treatment needs to begin quickly. While the answers below provide a general overview, the best approach can vary depending on the stage of the cancer and the patient’s overall health, symptoms and goals. FAQs include:

• What are the treatment options for small cell lung cancer?
• How is small cell lung cancer treated?

Benefit from world-class care at Moffitt Cancer Center

Moffitt delivers highly individualized care for patients with small cell lung cancer, taking a coordinated multispecialty approach that incorporates thoracic oncology, radiation oncology, pulmonary medicine, pathology, diagnostic imaging, supportive care and rehabilitation services. Each treatment plan is designed around the patient’s unique diagnosis, cancer stage, health profile and preferences, with a focus on both outcomes and quality of life.

If you would like to explore your treatment options for small cell lung cancer with a specialist in the Thoracic Oncology Program at Moffitt, you can request an appointment by calling 1-888-663-3488 or submitting a new patient registration form online. We do not require referrals.